Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

LifeTech Scientific to Market Broncus' Pulmonary Medical Devices in China

publication date: Oct 22, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
LifeTech Scientific, previously known as a China maker of cardiovascular medical devices, has joined with Broncus Technologies of the US to form a partnership that will commercialize Broncus’ LungPoint® Navigation System in China. The system enables physicians to plan bronchoscopic procedures, and then navigate to precise locations in the lungs to diagnose and treat lung cancers. The partnership is also being joined by DiNova Venture Partners of Shanghai and Themes Investment Partners of Hong Kong. Last week, Medtronic announced that it would pay $66 million to acquire a 26% stake in LifeTech. More details....

Stock Symbols: (HK: 8122) (NYSE: MDT)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors